Literature DB >> 21775731

Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm.

G Defazio1, G Abbruzzese, M S Aniello, M Bloise, C Crisci, R Eleopra, G Fabbrini, P Girlanda, R Liguori, A Macerollo, L Marinelli, D Martino, F Morgante, L Santoro, M Tinazzi, A Berardelli.   

Abstract

BACKGROUND: Although environmental and genetic factors may contribute to the etiology of blepharospasm, their relative contribution in causing familial and sporadic blepharospasm is unknown.
METHODS: First-degree relatives of 122 patients with primary blepharospasm were examined with a validated 2-step diagnostic procedure, including a screening questionnaire and examination of some relatives. Examiners were blinded to the questionnaire data for family history of probands. Data for demographic and clinical features, prior ophthalmologic complaints, and nondecaffeinated coffee intake were collected from probands before family investigation.
RESULTS: Dystonia was diagnosed in 27 relatives from 23 families (20% rate of family history for dystonia). No significant differences were found between familial and sporadic cases in the frequency of coffee drinking and eye diseases or in sex, age at onset, or tendency to spread. Multivariable conditional logistic analysis testing of 67 case patients and 127 family-matched unaffected siblings yielded a significant positive association between blepharospasm and prior eye diseases (adjusted odds ratio [OR] 2.5; 95% confidence interval [CI] 1.1-6.1; p = 0.03) and a significant inverse association between case status and ever coffee drinking (adjusted OR 0.23; 95% CI 0.1-0.8; p = 0.02).
CONCLUSIONS: The new information from this large family-based study on primary blepharospasm strongly supports eye diseases and coffee as risk factors for blepharospasm. The finding that the 2 environmental exposures exerted a similar influence on familial and sporadic blepharospasm, together with the convergent phenotypic expression in familial and sporadic cases, implies that familial and sporadic blepharospasm probably share a common etiologic background.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775731     DOI: 10.1212/WNL.0b013e3182299e13

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Botulinum toxin in the management of blepharospasm: current evidence and recent developments.

Authors:  Amy Hellman; Diego Torres-Russotto
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

Review 2.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

3.  Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.

Authors:  Xiao-Bo Fang; Meng-Shu Xie; Zu-Biao Song; Zhi-Gang Zhong; Ying Wang; Zi-Lin Ou; Chao Dang; Ling Li; Wei-Xi Zhang
Journal:  Neurol Sci       Date:  2019-11-19       Impact factor: 3.307

Review 4.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

Review 5.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

6.  Blepharospasm in a multiplex African-American pedigree.

Authors:  Jianfeng Xiao; Misty M Thompson; Satya R Vemula; Mark S LeDoux
Journal:  J Neurol Sci       Date:  2016-02-02       Impact factor: 3.181

7.  Predictors of alcohol responsiveness in dystonia.

Authors:  Johanna Junker; Valerie Brandt; Brian D Berman; Marie Vidailhet; Emmanuel Roze; Anne Weissbach; Cynthia Comella; Irene A Malaty; Joseph Jankovic; Mark S LeDoux; Alfredo Berardelli; Richard Barbano; Stephen G Reich; Joel S Perlmutter; H A Jinnah; Norbert Brüggemann
Journal:  Neurology       Date:  2018-10-19       Impact factor: 9.910

Review 8.  Botulinum toxin physiology in focal hand and cranial dystonia.

Authors:  Barbara Illowsky Karp
Journal:  Toxins (Basel)       Date:  2012-11-20       Impact factor: 4.546

9.  The environmental epidemiology of primary dystonia.

Authors:  Giovanni Defazio; Angelo F Gigante
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-05-03

10.  Phenotypic overlap in familial and sporadic primary adult-onset extracranial dystonia.

Authors:  Giovanni Defazio; Giovanni Abbruzzese; Paolo Girlanda; Rocco Liguori; Lucio Santoro; Michele Tinazzi; Alfredo Berardelli
Journal:  J Neurol       Date:  2012-05-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.